[embed_youtube”420″ height=”315″ src=”//www.youtube.com/embed/6ZmVXUYlQVU”]
Tag: alzheimer’s research
Certain Drugs Can Trigger or Slow Alzheimer’s
Good or Bad? Hmmm. Certain widely prescribed medications can trigger or slow the progress of Alzheimer’s disease, according to recently published research. A Mount Sinai Medical Center team screened 1,600 FDA-approved medications, using a computer algorithm to determine which drugs are associated with blocking or stimulating beta amyloid accumulation. Amyloid...
Beta Blockers May Reduce Alzheimer’s Risk (VIDEO)
[embed_youtube”420″ height=”315″ src=”http://www.youtube.com/embed/gWoi3HkJ7Ag”]
Beta Blockers May Reduce Alzheimer’s Risk
Men taking beta blockers to treat high blood pressure may also be benefiting from an unintended side effect: a reduced chance of brain changes associated with Alzheimer’s disease.åÊ åÊThe Honolulu-Asia Aging Study ÛÓ which will be discussed next month at the American Academy of Neurology’s annual meeting in San Diego...
Generation Alzheimer’s – New Report New Facts – Funding Needed
A new report from the Alzheimer’s Association called Generation Alzheimer’s sheds yet more light on the disease. “Alzheimeräó»s äóñ with its broad ranging impact on individuals, families, Medicare and Medicaid – has the power to bring the country to its financial knees,” said Robert J. Egge, vice president of Public...
Widely Used Drug Ineffective for Mild Alzheimer’s
As reported in Health.com, a drug widely used to treat mild Alzheimer’s disease appears to provide no benefit to this group of early stage patients, according to a new analysis of previously conducted research.æ Memantine, also known by its brand name, Namenda, is approved by the Food and Drug Administration...
Eat Drink and Be Merry – Scientists Said So!
Leave it to German researchers to conduct a study where they found that elderly adults who consume about two alcoholic beverages per day are at a significantly lower risk of developing Alzheimer’s disease and dementia than non-drinkers. Researchers said that study subjects were 30% less likely to develop dementia, and...
Alzheimer’s Plaques Might Begin in the Liver
The brain äóìplaquesäó commonly associated with Alzheimer’s disease might actually originate in the liver, according to scientists at Scripps Research Institute in a study published in The Journal of Neuroscience Research. Researchers evaluated the effect of three different genes on the presence of amyloid-beta plaques in the brain. Lower gene...
Alzheimer’s Test Clears Hurdle
From McKnight’s – An advisory committee to the U.S. Food and Drug Administration voted unanimously last week that the FDA should approve a brain scan that can identify the beta amyloid plaques that characterize Alzheimer’s in living persons. The FDA typically follows the advice of the advisory committee. Prior to...
Alzheimer’s Association Introduces TrialMatch
Every 70 seconds someone in America develops Alzheimer’s. In 2050, experts project there will be nearly one million new cases annually. The Alzheimer’s Association has developed TrialMatch, a confidential interactive tool that provides comprehensive clinical trial information and an individualized trial-matching service for people with Alzheimer’s disease and related dementias....